Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Vasopressin in the Elderly: Physiological Changes in Neuroendocrine Function and Urinary Secretion in Healthy Aging
Authors not listed
University Hospital, Basel, Switzerland · 2025
Abstract
Elderly people are at a high risk for disturbances in water homeostasis, with both hypo- and hypernatremia being more common with increasing age. Several changes in the physiology of the ageing body are responsible for this predisposition towards hypo- and hypernatremia, including diminished thirst perception, decreasing kidney function, and altered body composition. In addition, age-related changes in AVP secretion have been suggested, but findings remain inconclusive. Possibly, this controversy is due to measurement challenges of AVP.
Copeptin, a surrogate marker of AVP-release, is more stable and a reliable assay is commercially available. While copeptin stimulation and suppression has been studied in healthy volunteers, no study assessed possible changes in copeptin dynamics occurring with ageing.
Therefore, the aim of this study is to investigate copeptin levels in hypo- and hyperosmolar states in generally healthy elderly adults compared to young controls. The investigators hypothesize that both the suppression and stimulation of copeptin is impaired and that the overall range of variation is diminished with increasing age.
This is a monocentric open-labeled randomized controlled trial conducted at the university hospital Basel. All participants will be scheduled for a copeptin stimulation test using hypertonic saline infusion and a copeptin suppression test using water ingestion. The order of the two study visits will be randomized at study inclusion.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-07 MST
Cite this
APA
Anonymous. (2025). Vasopressin in the Elderly: Physiological Changes in Neuroendocrine Function and Urinary Secretion in Healthy Aging. <em>University Hospital, Basel, Switzerland</em>. https://clinicaltrials.gov/study/NCT06930300
Vancouver
Anonymous. Vasopressin in the Elderly: Physiological Changes in Neuroendocrine Function and Urinary Secretion in Healthy Aging. University Hospital, Basel, Switzerland. 2025.
BibTeX
@misc{anon2025Vasopr,
title = {Vasopressin in the Elderly: Physiological Changes in Neuroendocrine Function and Urinary Secretion in Healthy Aging},
author = {Anonymous},
journal = {University Hospital, Basel, Switzerland},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
VA Office of Research and Development 2013
Open access · US-GOV
Effects of Exercise Intervention on Aging-related Motor Decline (AGING)
University of Virginia 2003
Open access · US-GOV
Effect of Fasting on Ghrelin and Growth Hormone in Healthy Young and Older Adults
University of Pittsburgh 2025
Open access · US-GOV
Kaempferol Absorption and Pharmacokinetics Evaluation (K.A.P.E.)
Novartis Pharmaceuticals 2013
Open access · US-GOV
A Phase IV, Randomised, Single Masked Study Investigating the Efficacy and Safety of Ranibizumab "Inject and Extend" Using an Intensive Retinal Fluid Retreatment Regimen Compared to a Relaxed Retinal Fluid Retreatment Regimen in Patients With Wet Age-related Macular Degeneration (AMD)
The Journal of Clinical Endocrinology & Metabolism 2006
Open access · OA
Risk Factors for Diabetes Mellitus Type 2 and Metabolic Syndrome Are Comparable for Previously Growth Hormone-Treated Young Adults Born Small for Gestational Age (SGA) and Untreated Short SGA Controls
Jiangsu T-Mab Biopharma Co.,Ltd 2017
Open access · US-GOV